After more than 10 years of researching better treatments
for HIV patients, a new drug had been found in UK to lengthen the life
expectancy of the victims. <br>
<br>
The recent introduction of Pfizer’s drug Celsentri (Maraviroc) is truly helpful
for the patients as it guards the entrance of the immune system and blocks the
HIV, which in turn delays the process of developing into AIDS. <br>
<br>
Although the drug is not a cure-all treatment, this is an
option alternative that patients can look forward to since not all symptoms are
remedied by other available HIV drugs in the market. <br>
<br>
Many AIDS organizations have shown interest in the drug
saying this is a good sign of innovation and will aid to reduce the progression
of the disease into AIDS. <br>
<br>
Maraviroc comprised of three drugs collectively made into
one creating highly active anti-retroviral therapy (HAART) that lengthens the
lifespan of HIV patients. <br>
<br>
But recent findings showed that some patients have
resistance to the product making it not advisable for them to take. In August
2007, it was approved for public use in the U.S. market under the brand name
Selzentry. It is taken orally in combination with the other available
anti-retroviral drugs. <br>
<br>
Maynard Delfin is a blogger at http://www.com-x2.com